Mediso Ltd., headquartered in Hungary, is a leading innovator in the medical imaging industry, specialising in hybrid imaging solutions. Founded in 2000, the company has established a strong presence in Europe and beyond, focusing on advanced technologies that enhance diagnostic capabilities in nuclear medicine and molecular imaging. Mediso's core offerings include state-of-the-art PET/CT and SPECT/CT systems, renowned for their precision and efficiency. These products are distinguished by their unique design and integration capabilities, catering to the evolving needs of healthcare professionals. With a commitment to research and development, Mediso has achieved significant milestones, positioning itself as a trusted partner in the medical imaging sector. The company continues to drive advancements that improve patient outcomes and streamline clinical workflows.
How does Mediso Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Mediso Ltd.'s score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Mediso Ltd., headquartered in Hungary (HU), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Mediso Ltd. may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. In the context of the industry, many companies are increasingly adopting science-based targets and participating in initiatives such as the Science Based Targets initiative (SBTi) to align their operations with global climate goals. However, without specific emissions data or commitments, it is unclear how Mediso Ltd. positions itself within this evolving landscape of corporate climate responsibility.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Mediso Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
